SeaBridge Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.62M Buy
6,352
+6,125
+2,698% +$6.26M 1.1% 30
2026
Q1
$209K Sell
227
-10
-4% -$10.1K 0.04% 182
2025
Q4
$255K Buy
+237
New +$227K 0.04% 179
2024
Q4
Sell
-227
Closed -$201K 207
2024
Q3
$201K Hold
227
0.05% 148
2024
Q2
$206K Buy
+227
New +$182K 0.05% 146

Other funds holding LLY

SeaBridge Investment Advisors's LLY Position: Q2 2026 in Review

SeaBridge Investment Advisors increased its Eli Lilly (LLY) stake by 2,698% in Q2 2026, buying an estimated $6.26M and bringing the position to 6,352 shares worth $7.62M. The position accounts for 1.1% of the portfolio, ranked #30.

SeaBridge Investment Advisors first reported a position in LLY in Q2 2024 and has held it in 5 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SeaBridge Investment Advisors held 6,352 shares of Eli Lilly worth $7.62M as of Q2 2026.
  • SeaBridge Investment Advisors bought 6,125 Eli Lilly shares in Q2 2026, an estimated $6.26M.
  • Eli Lilly made up 1.1% of SeaBridge Investment Advisors's portfolio in Q2 2026, its #30 holding.
  • SeaBridge Investment Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 5 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SeaBridge Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.